Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
General Research Article

Simultaneous Detection of Phillyrin and its Three Metabolites in Rat Bile, Excrement and Urine via HPLC-ESI-MS/MS Quantitative Method

Author(s): Xizhe Liu, Feigao Li and Lantong Zhang*

Volume 18, Issue 1, 2022

Published on: 17 January, 2021

Page: [88 - 100] Pages: 13

DOI: 10.2174/1573412917666210118115735

Abstract

Introduction: Phillyrin, the main pharmacological component of Forsythia suspensa, exhibits a wide variability of therapeutic activities, such as anti-oxidative stress, free radicalclearing, antibacterial activity, hepatic protection, restoration of endothelial glycocalyx damage, prevention of bone loss, attenuation of inflammatory responses, and so on. Previous research has found that phillyrin is not easily absorbed by the body and is rarely excreted into bile, excrement and urine, suggesting that phillyrin circulates primarily in the form of metabolites.

Materials and Methods: In the present study, HPLC-ESI-MS/MS method was used for the simultaneous detection of phillyrin and its three metabolites in rat bile, excrement and urine samples. Liquid-liquid extraction with ethyl acetate was carried out for the pretreatment of bile and urine samples, while excrement samples were subjected to ultrasonic pretreatment with acetone. Chromatographic separation was performed on a C18 column with gradient elution. A tandem mass system coupled with a TurboIonSpray interface operating in simultaneous positive and negative ion multiple reaction monitoring modes was employed for the simultaneous detection of the analytes.

Results: The proposed method demonstrated excellent accuracy and repeatability.

Conclusion: This method was successfully applied for the pharmacokinetic evaluation of phillyrin and its three metabolites simultaneously.

Keywords: LC-MS, determination, phillyrin, metabolite, pharmacokinetic, excretion.

« Previous Next »
Graphical Abstract

[1]
The Hunan University of Traditional Chinese Medicine has released a prescription for preventing 2019-ncov infection. Hunan. J. Tradit. Chin. Med., 2020, 36(02), 2.
[2]
Wang, Z.; Xia, Q.; Liu, X.; Liu, W.; Huang, W.; Mei, X.; Luo, J.; Shan, M.; Lin, R.; Zou, D.; Ma, Z. Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: A review. J. Ethnopharmacol., 2018, 210, 318-339.
[http://dx.doi.org/10.1016/j.jep.2017.08.040] [PMID: 28887216]
[3]
Xia, E.Q.; Ai, X.X.; Zang, S.Y.; Guan, T.T.; Xu, X.R.; Li, H.B. Ultrasound-assisted extraction of phillyrin from Forsythia suspensa. Ultrason. Sonochem., 2011, 18(2), 549-552.
[http://dx.doi.org/10.1016/j.ultsonch.2010.09.015] [PMID: 20980187]
[4]
Hwang, Y.H.; Jang, S.A.; Kim, T.; Ha, H. Forsythia suspensa protects against bone loss in ovariectomized mice. Nutrients, 2019, 11(8), 1831.
[http://dx.doi.org/10.3390/nu11081831] [PMID: 31398803]
[5]
Zhou, M.Y.; Huo, J.H.; Wang, W.M. Identification of 45 Kinds of Chemical Components of Forsythia suspensa by UPLC-Q-TOF-MS. China Pharmacy, 2019, 30(22), 3067-3073.
[6]
Shao, S.Y.; Feng, Z.M.; Yang, Y.N.; Jiang, J.S.; Zhang, P.C. Eight new phenylethanoid glycoside derivatives possessing potential hepatoprotective activities from the fruits of Forsythia suspensa. Fitoterapia, 2017, 122, 132-137.
[http://dx.doi.org/10.1016/j.fitote.2017.09.008] [PMID: 28911849]
[7]
Hwang, Y.H.; Kim, D.G.; Li, W.; Yang, H.J.; Yim, N.H.; Ma, J.Y. Anti-inflammatory effects of Forsythia suspensa in dextran sulfate sodium-induced colitis. J. Ethnopharmacol., 2017, 206, 73-77.
[http://dx.doi.org/10.1016/j.jep.2017.05.011] [PMID: 28502906]
[8]
Zhang, N. Extraction and pharmacological action of forsythia major active ingredients. World Latest Medicine Information (Electronic Version), 2019, 19(91), 180-189.
[9]
Liu, X.Z.; Yu, S.H.; Huo, H.L.; Li, F.G.; Sheng, N.; Zhang, L.T. HPLC-ESI-MS/MS quantitative method for simultaneous analysis of five bioactive constituents of Forsythia suspensa in rat bile after oral administration of Forsythia suspensa extract. J. Liq. Chromatogr. Relat. Technol., 2012, 35, 1-17.
[http://dx.doi.org/10.1080/10826076.2011.644051]
[10]
Liu, X.Z.; Sheng, N.; Huo, H.L.; Meng, Y.; Zhang, L.T. Metabolites of phillyrin by rat intestinal flora. Chin. Pharm. J.,, 2012, 43(6), 38-42.
[11]
Wang, H.; Zhang, X.; Jia, P.; Zhang, Y.; Tang, S.; Wang, H.; Li, S.; Yu, X.; Li, Y.; Zhang, L. Metabolic profile of phillyrin in rats obtained by UPLC-Q-TOF-MS. Biomed. Chromatogr., 2016, 30(6), 913-922.
[http://dx.doi.org/10.1002/bmc.3629] [PMID: 26425840]
[12]
Li, C.; Yao, Z.H.; Qin, Z.F.; Zhang, J.B.; Cao, R.Y.; Dai, Y.; Yao, X.S. Isolation and identification of phase I metabolites of phillyrin in rats. Fitoterapia, 2014, 97, 92-97.
[http://dx.doi.org/10.1016/j.fitote.2014.05.011] [PMID: 24879901]
[13]
Jan, K.C.; Hwang, L.S.; Ho, C.T. Biotransformation of sesaminol triglucoside to mammalian lignans by intestinal microbiota. J. Agric. Food Chem., 2009, 57(14), 6101-6106.
[http://dx.doi.org/10.1021/jf901215j] [PMID: 19537732]
[14]
Wang, G.N.; Pan, R.L.; Liao, Y.H.; Chen, Y.; Tang, J.T.; Chang, Q. An LC-MS/MS method for determination of forsythiaside in rat plasma and application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2010, 878(1), 102-106.
[http://dx.doi.org/10.1016/j.jchromb.2009.11.029] [PMID: 19945919]
[15]
Alothman, Z.A.; Rahman, N.; Siddiqui, M.R. Review on pharmaceutical impurities, stability studies and degradation products: an analytical approach. Rev. Adv. Sci. Eng., 2013, 2(2), 155-166.
[http://dx.doi.org/10.1166/rase.2013.1039]
[16]
Masoom, R.S.; Zeid, A.A.; Nafisur, R. Analytical techniques in pharmaceutical analysis: A review. Arab. J. Chem., 2017, 10, S1409-S1421.
[http://dx.doi.org/10.1016/j.arabjc.2013.04.016]
[17]
Nafisur, R.; Syed, N.; Hejaz, A.; Wu, H.F. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accredit. Qual. Assur., 2006, 11, 69-74.
[http://dx.doi.org/10.1007/s00769-006-0095-y]
[18]
Tron, C.; Rayar, M.; Petitcollin, A.; Beaurepaire, J.M.; Cusumano, C.; Verdier, M.C.; Houssel-Debry, P.; Camus, C.; Boudjema, K.; Bellissant, E.; Lemaitre, F. A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients. J. Chromatogr. A, 2016, 1475, 55-63.
[http://dx.doi.org/10.1016/j.chroma.2016.10.075] [PMID: 27837999]
[19]
Du, Y.; Liu, P.; Shi, X.; Jin, Y.; Wang, Q.; Zhang, X.; Sheng, X.; Zhang, L. A novel analysis method for diterpenoids in rat plasma by liquid chromatography-electrospray ionization mass spectrometry. Anal. Biochem., 2010, 407(1), 111-119.
[http://dx.doi.org/10.1016/j.ab.2010.07.009] [PMID: 20643094]
[20]
Ye, L.H.; Li, Y.X.; Peng, C.; Gong, X.H.; Zheng, X.G. Determination of phillygenin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies. Eur. J. Drug Metab. Pharmacokinet., 2013, 38(3), 201-207.
[http://dx.doi.org/10.1007/s13318-013-0128-y] [PMID: 23564502]

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy